The Scottish intercollegiate guidelines 174 identify a role for lipid-lowering drugs in reducing ischaemic heart disease events but not all cause mortality in people with no known arterial disease, compared with placebo
---
 nice.evidencecategory: Ia
[@Linden_2011]
